- News Home
5 December 2013 11:26 am ,
Vol. 342 ,
Dyslexia, a learning disability that hinders reading, hasn't been associated with deficits in vision, hearing, or...
Exotic, elusive, and dangerous, snakes have fascinated humankind for millennia. They can be hard to find, yet their...
Researchers have sequenced and analyzed the first two snake genomes, which represent two evolutionary extremes. The...
Snake venoms are remarkably complex mixtures that can stun or kill prey within minutes. But more and more researchers...
At age 30, Dutch biologist Freek Vonk has built up a respectable career as a snake scientist. But in his home country,...
Since arriving on the island of Guam in the 1940s, the brown tree snake ( Boiga irregularis ) has extirpated native...
An animal rights group known as the Nonhuman Rights Project filed lawsuits in three New York courts this week in an...
Researchers have been hot on the trail of the elusive Denisovans, a type of ancient human known only by their DNA and...
- 5 December 2013 11:26 am , Vol. 342 , #6163
- About Us
NIH Program on Undiagnosed Diseases Overwhelmed With Cases
1 July 2011 12:13 pm
The National Institutes of Health's (NIH's) high-profile initiative to diagnose mystery illnesses is pausing to catch its breath.
The Undiagnosed Diseases Program was started in 2008 to help people desperate for diagnosis and to use the discovery of novel diseases to learn more about human biology. But as of today, the program will temporarily stop accepting new applications for cases to be studied because of an "overwhelming number of applications already received," according to the note posted on the program's Web site.
"We've been flooded for a while. This is a last-ditch effort to catch up," says the program's head William Gahl, a biochemical geneticist at the National Human Genome Research Institute. "We want to be able to devote more time to the conditions we've already seen."
The Undiagnosed Diseases Program has received some 5400 inquiries, and a full application, with the medical records of the ill person, were submitted on about 1900, according to Gahl. The program has so far accepted around 450 of those applicants, but has had time to only investigate about 350 cases so far—each person typically comes in for about a week of studies at the clinical center on NIH's Bethesda, Maryland, campus. Gahl says that applications already submitted will still be considered for such a full investigation. And he hopes the program, which published its first discovery of a new genetic disorder earlier this year, will resume accepting new case applications in a few months.